NO964451D0 - X-ray contrast compositions containing pharmaceutically acceptable clays - Google Patents

X-ray contrast compositions containing pharmaceutically acceptable clays

Info

Publication number
NO964451D0
NO964451D0 NO964451A NO964451A NO964451D0 NO 964451 D0 NO964451 D0 NO 964451D0 NO 964451 A NO964451 A NO 964451A NO 964451 A NO964451 A NO 964451A NO 964451 D0 NO964451 D0 NO 964451D0
Authority
NO
Norway
Prior art keywords
pharmaceutically acceptable
compositions containing
ray contrast
containing pharmaceutically
contrast compositions
Prior art date
Application number
NO964451A
Other languages
Norwegian (no)
Other versions
NO964451L (en
Inventor
Stephen B Ruddy
Gregory L Mcintire
Mary E Roberts
John Toner
Edward R Bacon
Tom Caufield
Eugene R Cooper
Brent D Douty
Carl R Illig
Kimberly Estep
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/230,580 external-priority patent/US5476646A/en
Priority claimed from US08/236,287 external-priority patent/US5424056A/en
Priority claimed from US08/237,502 external-priority patent/US5492687A/en
Priority claimed from US08/239,090 external-priority patent/US5484585A/en
Priority claimed from US08/247,424 external-priority patent/US5360604A/en
Priority claimed from US08/247,438 external-priority patent/US5531979A/en
Priority claimed from US08/249,424 external-priority patent/US5472682A/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO964451D0 publication Critical patent/NO964451D0/en
Publication of NO964451L publication Critical patent/NO964451L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
NO964451A 1994-04-21 1996-10-18 X-ray contrast compositions containing pharmaceutically acceptable clays NO964451L (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US08/230,580 US5476646A (en) 1992-05-01 1994-04-21 X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays
US08/236,287 US5424056A (en) 1993-03-01 1994-04-29 X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays
US08/237,502 US5492687A (en) 1993-03-11 1994-05-03 Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/239,090 US5484585A (en) 1993-03-11 1994-05-05 Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,424 US5360604A (en) 1994-04-14 1994-05-23 X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
US08/247,438 US5531979A (en) 1993-02-02 1994-05-23 Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/249,424 US5472682A (en) 1993-03-31 1994-05-26 Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
PCT/GB1995/000566 WO1995028969A1 (en) 1994-04-21 1995-03-16 X-ray contrast compositions containing pharmaceutically acceptable clays

Publications (2)

Publication Number Publication Date
NO964451D0 true NO964451D0 (en) 1996-10-18
NO964451L NO964451L (en) 1996-12-18

Family

ID=27569393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964451A NO964451L (en) 1994-04-21 1996-10-18 X-ray contrast compositions containing pharmaceutically acceptable clays

Country Status (9)

Country Link
EP (1) EP0756497A1 (en)
JP (1) JPH09512029A (en)
CN (1) CN1147206A (en)
AU (1) AU1897795A (en)
CA (1) CA2187019A1 (en)
FI (1) FI964212A0 (en)
HU (1) HUT76304A (en)
NO (1) NO964451L (en)
WO (1) WO1995028969A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466440A (en) * 1994-12-30 1995-11-14 Eastman Kodak Company Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JP4670229B2 (en) * 2003-06-10 2011-04-13 味の素株式会社 Composition for gastrointestinal imaging in CT colonography
AU2005214167B2 (en) 2004-02-13 2008-08-07 Warner-Lambert Company Llc Androgen receptor modulators
JP2007532621A (en) 2004-04-13 2007-11-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Androgen modulator
WO2005102990A1 (en) 2004-04-22 2005-11-03 Warner-Lambert Company Llc Androgen modulators
WO2006006065A1 (en) 2004-07-08 2006-01-19 Warner-Lambert Company Llc Androgen modulators
CN1330380C (en) * 2005-03-18 2007-08-08 山东师范大学 X-ray contrast agent composition and its preparation method
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
EP3984560A1 (en) 2013-03-15 2022-04-20 The Regents of the University of California Enteric ct contrast material based on low-z atoms
EP3033012A4 (en) * 2013-08-16 2017-04-19 The Regents of the University of California Silicone-based enteric ct contrast material
CN106075476B (en) * 2016-07-30 2019-05-31 温州市人民医院 A kind of contrast agent

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) * 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (en) * 1954-01-08 1959-05-15 Schering Corp Use as radiopaque agents of polyiodinated phenoxy fatty acids
CA985626A (en) * 1970-03-10 1976-03-16 E.R. Squibb And Sons Coating composition for moist surface
CA2094893A1 (en) * 1992-05-01 1993-11-02 Carl R. Illig X-ray contrast compositions containing film-forming materials
US5260049A (en) * 1992-05-01 1993-11-09 Sterling Winthrop Inc. X-ray contrast compositions comprising alkoxyphenols
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5312616A (en) * 1993-03-11 1994-05-17 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5344638A (en) * 1993-03-11 1994-09-06 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract
US5360604A (en) * 1994-04-14 1994-11-01 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

Also Published As

Publication number Publication date
JPH09512029A (en) 1997-12-02
HU9602908D0 (en) 1996-12-30
AU1897795A (en) 1995-11-16
FI964212A (en) 1996-10-18
EP0756497A1 (en) 1997-02-05
WO1995028969A1 (en) 1995-11-02
CN1147206A (en) 1997-04-09
NO964451L (en) 1996-12-18
MX9604899A (en) 1998-03-31
HUT76304A (en) 1997-07-28
FI964212A0 (en) 1996-10-18
CA2187019A1 (en) 1995-11-02

Similar Documents

Publication Publication Date Title
FI963421A (en) Oral excipient compositions
NO972409D0 (en) dose indicating
BR9508844A (en) Oral composition
FI942713A0 (en) Oral compositions for reducing oral odors
DK0769017T3 (en) Therapeutic compounds
FI955311A (en) Pharmaceutical composition base
BR9506536A (en) Oral composition
HUT74746A (en) Pharmaceutical compositions containing p antagonist
BR9510467A (en) Oral compositions
EP0755250A4 (en) Benzamide-containing pharmaceutical compositions
NO964451D0 (en) X-ray contrast compositions containing pharmaceutically acceptable clays
BR9510307A (en) Oral compositions
BR9507768A (en) Pharmaceutical composition
ITMI941169A0 (en) PHARMACEUTICAL FORMULATIONS
ITMI942166A0 (en) PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
DE69512984D1 (en) X-RAY UNIT
FI951155A0 (en) Pharmaceutical preparation
GB2295825B (en) Pharmaceutical compositions
BR9510459A (en) Oral compositions
FI952725A (en) Radiographic Unit
FI962738A (en) Pharmaceutical compositions
DE59510194D1 (en) can
IT1272935B (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN
GB2308545A (en) Pharmaceutical compositions
SE9402924D0 (en) Novel pharmaceutical composition